Cargando…
Current Management of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors
The clinical outcomes and survival of tyrosine kinase inhibitor (TKI)-treated patients with chronic myeloid leukemia (CML) have been significantly improved. The aim of this editorial is to outline critical steps of TKI administration practices during the long-term clinical course of CML based on dat...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Galenos Publishing
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3878539/ https://www.ncbi.nlm.nih.gov/pubmed/24385803 http://dx.doi.org/10.4274/Tjh.2013.0108 |